An immunocytochemical study of MHC class I expression on human Langerhans cells and melanocytes

Journal of Pathology

Volumn 181, Issue 4, 1997, Pages 419-425

  Moseley, Robin P ^a   Brown, James I ^a   Auld, John ^a   Mumtaz, Hamid ^a   Rainey, Andrew J ^b   Kirkham, Nigel ^b   Gelsthorpe, Keith ^c   Masters, Ruth ^d   Smith, Mark E F ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d Brentwood Transfusion Centre   (United Kingdom)

Author keywords

HIV; HLA class I; HLA DR; Langerhans cells; melanocytes; melanoma; MHC class I

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OKT 6;

ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; HAIR FOLLICLE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LANGERHANS CELL; MELANOCYTE; PRIORITY JOURNAL; SCALP;

EID: 0031009244     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199704)181:4<419::AID-PATH796>3.0.CO;2-W     Document Type: Article

References (64)

1. Fleming KA, McMichael A, Morion JA, Woods J. McGee JO. Distribution of HLA class I antigens in normal human tissue and in mammary cancer. J Clin Palhol 1981; 34: 779-784.
2. Daar AS, Fuggle SV, Fabre JW, Ting A, Morri PJ. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984; 38: 287-292.
3. Natali PG, Bigotti A, Nicotra MR, Viora M, Manfredi D, Ferrone S. Distribution of human class I (HLA-A, B. C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 1984; 44: 4679-4687.
4. Ruiter DJ, Bhan AK, Harrist TJ, Sober AJ, Mihm MC. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol 1982; 129: 2808-2815.
5. Harrist TJ, Ruiter DJ, Mihm MC Jr, Bhan AK. Distribution of major histocompatibility antigens in normal skin. Br J Dermatol 1983; 109: 623-633.
6. 2 microglobulin on the membrane of the keratinocyte in premalignant skin disorders. Br J Dermatol 1981; 104: 515-519.
7. Bronstein BR, Murphy GF, Harrist TJ, Ruiter DJ, Mihm MC, Bhan AK. Location of HLA-A, B. C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study. J Invest Dermatol 1983; 80: 481-484.
8. Holden CA, Sanderson AR, MacDonald DM. Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: evidence using monoclonal antibodies. J Am Acad Dermatol 1983; 9: 867-871.
9. Romani N, Stingl G, Tschachler E, et al. The Thy-1-bearing cell of murine epidermis: a distinctive leukocyte perhaps related to natural killer cells. J Exp Med 1985; 161: 1368-1383.
10. b mutant skin allografts differing at class I MHC. Nature 1986; 322: 829-831.
11. + murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex. Proc Natl Acad Sci USA 1986; 83: 7438-7442.
12. Lenz A, Heufler C, Rammensee H, et al. Murine epidermal Langerhans cells express significant amounts of class I major histocompatibility complex antigens. Pruc Natl Acad Sci USA 1989; 86: 7527-7531.
13. Tripathi BJ, Tripathi RC, Wong P, Raja S. Expression of HLA by the human trabecular meshwork and corneal endothelium. Exp Eye Res 1990; 51: 269-276.
14. Van Duinen SG, Mauw BJ, De Graaff-Reitsma CB, Ruiter DJ. Immuno-electron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells. Lab Invest 1984; 50: 733-741.
15. Gielen V, Schmitt D, Thivolet J. HLA class I antigen (heavy and light chain) expression by Langerhans cells and keratinocytes of the normal human epidermis: ultrastructural quantification using immunogold labelling procedure. Arch Dermatol Res 1988; 280: 131-136.
16. Witmer-Pack MD, Valinsky J, Olivier W, Steinman RM. Quantitation of surface antigens on cultured murine epidermal Langerhans cells: rapid and selective increase in the level of surface MHC products. J Invest Dermatol 1988; 90: 387-394.
17. Romani N, Lenz A, Glassel H, et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 1989; 93: 600-609.
18. Teunissen MBM, Wormmeester J, Krieg SR, et al. Human Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol 1990; 94: 166-173.
19. Barnstable CJ, Bodmer WF, Brown G, et al. Production of monoclonal antibodies to group A erythrocytes. HLA and other human cell surface antigens - new tools for genetic analysis. Cell 1978; 14: 9-20.
20. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979; 47: 3-61.
21. Kennedy LJ, Marsh SGE, Bodmer J. Cytotoxic monoclonal antibodies. In: Dupont B, ed. Immunobiology of HLA. New York: Springer-Verlag, 1987; 301-305.
22. Bodmer JG, Moses JH, Marsh SGE. Report on the monoclonal antibodies used in the Eleventh International Histocompatibility Workshop. 1992; 1: 264-279 (Abstract).
23. Wan AM, Ennis P, Parham P, Holmes N. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J Immunol 1986; 137: 3671-3674.
24. Muller CA, Engler-Blum G, Gekeler V, Steiert I, Schmidt H. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 1989; 30: 200-207.
25. Lutz CT, Smith KD, Greazel NS, et al. Bw4-reactive and Bw6-reactive antibodies recognise multiple distinct HLA structures that partially overlap in the alpha-1 helix. J Immunol 1994; 153: 4099-4110.
26. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995; 181: 1133-1144.
27. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. 1992; 1: 1065-1220 (Abstract).
28. Epenetos AA, Bobrow LG, Adams TE, Collins CM, Isaacson PG, Bodmer WF. A monoclonal antibody that detects HLA-D region antigen in routinely fixed, wax embedded sections of normal and neoplastic tissues. J Clin Pathol 1985; 38: 12-17.
29. Tomita Y, Montague PM, Hearing VJ. Anti-T4 tyrosinase monoclonal antibodies - specific markers for melanocytes. J Invest Dermatol 1985; 85: 426-430.
30. Jimenez M, Kameyama K, Maloy WL, Tomita Y, Hearing VJ. Mammalian tyrosinase: biosynthesis, processing and modulation by melanocyte stimulating hormone. Proc Natl Acad Sci USA 1988; 85: 3830-3834.
31. Cui J, Arita Y, Bystryn J. Characterisation of vitiligo antigens. Pigment Cell Res 1995; 8: 53-59.
32. McMichael AJ, Fitch JR, Galfre G, Mason DY, Fabre JW, Milstein C. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol 1979; 9: 205-210.
33. Lever WF, Schaumburg-Lever G. Histopathology of the Skin. Philadelphia: J. B. Lippincott. 1990.
34. Parham P, Androlewicz MJ, Brodsky FM, Holmes NJ, Ways JP. Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J Immunol Methods 1982; 53: 133-173.
35. Bishara A, Nelken D, Bonavida B, Brautbar C. Enzyme-linked immuno-sorbent assay for determination of HLA: gene dose etfect. Tissue Antigens 1984; 23: 284-289.
36. Nosek J, Hinzova E, Vorlicek J. Quantitative estimation of HLA-A and HLA-B antigens carrying the Bw4 supertypic specificity in human peripheral blood lymphocytes. Immunogenetics 1987; 26: 273-281.
37. Breathnach SM. The Langerhans cell. Br J Dermatol 1988; 119: 463-469.
38. Bos JD, Kapsenberg ML. The skin immune system. Its cellular constituents and their interactions. Immunol Today 1986; 7: 235-240.
39. Mommaas AM, Mulder AA, Out CJ, et al. Distribution of HLA class II molecules in epidermal Langerhans cells in situ. Eur J Immunol 1995; 25: 520-525.
40. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483-1493.
41. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145: 2833-2838.
42. Yamashita K, Yano A. Migration of murine epidermal Langerhans cells to regional lymph nodes: engagement of major histocompatibility complex class II antigens induces migration of Langerhans cells. Microbiol Immunol 1994; 38: 567-574.
43. Sontag Y, Guikers CL, Vink AA, et al. Cells with UV-specific DNA damage are present in murine lymph nodes after in vivo UV irradiation. J Invest Dermatol 1995; 104: 734-738.
44. Chu T, Jaffe R. The normal Langerhans cell and the LCH cell. Br J Cancer 1994; 70: S4-S10.
45. Ludewig B, Holzmeister J, Gentile M, et al. Replication pattern of human immunodeficiency virus type 1 in mature Langerhans cells. J Gen Vorol 1995; 76: 1317-1325.
46. Thomas JA, Wakeling WF, Imrie SF, Sloane JP, Powles RL, Lawler SD. Chimerism in skin of bone marrow transplant recipients. Transplantation 1984; 38: 475-478.
47. Tschachler E, Groh V, Popovic M, et al. Epidermal Langerhans cells - a target for HTLV-III/LAV infection. J Invest Dermatol 1987; 88: 233-237.
48. Rappersberger K, Gartner S, Schenck P, et al. Langerhans cells are an actual site of HIV-1 replication. Intervirology 1988; 29: 185-194.
49. Stingl G, Rappersberger K, Tschachler E, et al. Langerhans cells in HIV-1 infection. J Am Acad Dermatol 1990; 22: 1210-1217.
50. Zambruno G, Mori L, Marconi A, et al. Detection of HIV-1 in epidermal Langerhans cells of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol 1991; 96: 979-982.
51. Giannetti A, Zambruno G, Cimarelli A, et al. Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr 1993; 6: 329-333.
52. Blauvelt A, Clerici M, Lucey DR, et al. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol 1995; 154: 3506-3515.
53. Joly E, Mucke L, Oldstone MBA. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 1991; 253: 1283-1285.
54. Pereira RA, Tscharke DC, Simmons A. Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J Exp Med 1994; 180: 841-850.
55. Woolfson A, Milstein C. Alternative splicing generates secretory isoforms of human CD1. Proc Natl Acad Sci USA 1994; 91: 6683-6687.
56. Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytotoxic lymphocytes. Nature 1989; 341: 447-450.
57. Moulon C, Peguet-Navarro J, Schmitt D. A potential role for CD1a molecules on human epidermal Langerhans cells in allogeneic T-cell activation. J Invest Dermatol 1991; 97: 524-528.
58. Lundqvist C, Hammarstrom ML. T-cell receptor gamma delta-expressing intraepithelial lymphocytes are present in normal and chronically inflamed human gingiva. Immunology 1993; 79: 38-45.
59. Ruiter D, Bergman W, Welvaart K, et al. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. Cancer Res 1984; 44: 3930-3935.
60. 2 microglobulin expression in normal melanocytes, nevocelluar nevi, and malignant melanoma. J Invest Dermatol 1989; 92: 243S-247S.
61. Bergman W, Ruiter DJ, Scheffer E, van Vlolen WA. Melanocytic atypia in dysplastic nevi: immunohistochemical and cytophotometric analysis. Cancer 1988; 61: 1660-1666.
62. Smit N, Le-Poole I, van den Wijngaard R, Tigges A, Westerhof W. Das P. Expression of different immunological markers by cultured human melanocytes. Arch Dermatol Res 1993; 285: 356-365.
63. Marincola FM, Shamamian P, Alexander RB, et al. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol 1994; 153: 1225-1237.
64. Krasagakis K, Garbe C, Eberle J, Orfanos CE. Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro. Arch Dermatol Res 1995; 287: 259-265.